Navigation Links
EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application
Date:3/2/2011

n alfa injection). In addition, EMD Serono is growing its expertise and presence in the area of oncology, with more than 10 projects currently in development. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with more than 1100 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts.

For more information, please visit www.emdserono.com

About Merck KGaAMerck is a global pharmaceutical and chemical company with total revenues of euro 9.3 billion in 2010, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit www.merckserono.com or www.merck.de


'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. EMD Serono Named as a Top Employer by Science Magazine
2. Merck Serono Named as a Top Employer by Science Magazine
3. Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinsons Disease
4. EMD Serono Launches Landmark Patient Registry for Egg Freezing
5. Merck Serono Launches Strategic Venture Capital Fund
6. Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
7. Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)
8. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
9. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
10. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
11. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 LabStyle Innovations Corp. (OTCQB: ... today announced it recently closed a round of ... used to support the global rollout and initial ... cloud-based, diabetes management solution that includes novel software ... glucose monitoring device, and for working capital purposes. ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for excessive ... commercially available new FDA approved system in the last 14 years, and the only ... Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and ...
(Date:8/28/2015)... August 28, 2015 According to ... Sera, Cryogenic Storage Systems, Thawing Equipment, Alarms), by Biospecimen ... Clinical Trials), End User - Global Forecast to 2020", ... to reach USD 3,731.03 Million by 2020 from USD ... 11.65% between 2015 and 2020. Browse ...
(Date:8/28/2015)... ... 2015 , ... Riordan-McKenna Institute founders, stem cell ... the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic Therapies ... knee wound. , The case involved a 78-year-old male, who presented with a ...
Breaking Biology Technology:LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4
... (OTC Bulletin Board: CSBR ), a company engaged ... data to enhance the value of oncology drugs, today announced ... July 31, 2010.  Full details of the Company,s financial results ... www.championsbiotechnology.com . Total revenues for the first quarter ...
... Form of... -- REYKJAVIK, Iceland, September 13, 2010 ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... Trial Amended ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
Cached Biology Technology:Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 4deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 2deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 3deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 4deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 5deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 6deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 7deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma 8Resverlogix's Phase 2 ASSURE Trial Amended 2Resverlogix's Phase 2 ASSURE Trial Amended 3Resverlogix's Phase 2 ASSURE Trial Amended 4Resverlogix's Phase 2 ASSURE Trial Amended 5Resverlogix's Phase 2 ASSURE Trial Amended 6Resverlogix's Phase 2 ASSURE Trial Amended 7
(Date:8/31/2015)... , August 31, 2015 Growing ... technology in government digitization projects to drive India ... recently published TechSci Research report, " India Biometrics Market Forecast ... is projected to grow at a CAGR of ... is anticipated on account of extensive use of biometric technology ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ) has announced ... Market - Growth, Trends & Forecasts (2014-2020)" report ... Biomedical Sensors market is estimated at $0.23 billion by ... 2014-2020 The near future will bring biomedical ... each individual. These sensors can be set to trigger ...
(Date:8/28/2015)... 28, 2015 According to a ... by Assessment Type (Pen & Paper Based, Hosted, Biometrics), ... Learning, Academic Research), Vertical and Region - Global Forecast ... Market to grow from USD 2.4 Billion in 2015 ... Annual Growth Rate (CAGR) of 25.6% from 2015 to ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4
... 2009) As stroma the supportive framework of the prostate ... genes occur that induce the formation of new structures such as ... College of Medicine in a report that appears in the current ... this study, using special techniques and gene chips that allowed them ...
... Merck Irving S. Sigal Memorial Award is being presented ... Infectious Disease Initiative at the Broad Institute of MIT ... Medicine at Harvard Medical School. Sponsored by Merck Research ... presented in memory of Irving S. Sigal, who was ...
... technology - which makes plants significantly more resistant to ... US agricultural company Becker Underwood in collaboration with Plant ... with jasmonic acid - a chemical naturally produced by ... attack. But crops treated with the chemical don,t grow ...
Cached Biology News:Gene activity reveals dynamic stroma microenvironment in prostate cancer 2Gene activity reveals dynamic stroma microenvironment in prostate cancer 3Natural seed treatment could drastically cut pesticide use 2
...
...
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity....
...
Biology Products: